RIVA, ELISABETTA
 Distribuzione geografica
Continente #
AS - Asia 6.598
NA - Nord America 3.460
EU - Europa 1.277
SA - Sud America 404
AF - Africa 63
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 25
Totale 11.852
Nazione #
SG - Singapore 4.950
US - Stati Uniti d'America 3.322
CN - Cina 739
IT - Italia 640
HK - Hong Kong 480
BR - Brasile 256
GB - Regno Unito 201
VN - Vietnam 150
FR - Francia 141
DE - Germania 84
CA - Canada 69
IN - India 63
AR - Argentina 45
BD - Bangladesh 45
NL - Olanda 37
ID - Indonesia 32
MX - Messico 31
EC - Ecuador 30
RU - Federazione Russa 27
TR - Turchia 25
AU - Australia 23
CO - Colombia 22
ZA - Sudafrica 22
FI - Finlandia 21
UA - Ucraina 21
PL - Polonia 17
CZ - Repubblica Ceca 16
ES - Italia 15
PY - Paraguay 15
PH - Filippine 14
VE - Venezuela 14
JP - Giappone 12
SA - Arabia Saudita 12
IQ - Iraq 11
MA - Marocco 11
MD - Moldavia 10
PK - Pakistan 10
MY - Malesia 9
CL - Cile 8
EE - Estonia 8
PE - Perù 7
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
HN - Honduras 5
TH - Thailandia 5
BE - Belgio 4
CH - Svizzera 4
CR - Costa Rica 4
GP - Guadalupe 4
IL - Israele 4
SE - Svezia 4
UY - Uruguay 4
AT - Austria 3
EG - Egitto 3
ET - Etiopia 3
JM - Giamaica 3
KE - Kenya 3
KH - Cambogia 3
KZ - Kazakistan 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PR - Porto Rico 3
UZ - Uzbekistan 3
AM - Armenia 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
IE - Irlanda 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
LT - Lituania 2
LY - Libia 2
NI - Nicaragua 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
SV - El Salvador 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DK - Danimarca 1
GA - Gabon 1
GR - Grecia 1
Totale 11.811
Città #
San Jose 847
Ashburn 805
Singapore 525
Hong Kong 478
Rome 376
Hefei 283
Council Bluffs 215
Boardman 194
Beijing 171
London 157
Columbus 147
Lauterbourg 121
Shanghai 98
Dallas 86
Ho Chi Minh City 62
Santa Clara 56
New York 53
Los Angeles 45
San Francisco 36
Milan 33
Munich 31
Phoenix 29
São Paulo 29
Toronto 27
Seattle 26
Hanoi 25
Pune 24
Washington 20
Amsterdam 19
Warsaw 16
West Jordan 16
Chicago 15
Brooklyn 14
Brno 13
Quito 12
Atlanta 11
Denver 11
Helsinki 11
Mexico City 11
Boston 10
Guayaquil 10
Melbourne 10
Naples 10
Sydney 10
Tokyo 10
Turku 10
Brescia 9
Buffalo 9
Hangzhou 9
Las Vegas 9
Montreal 9
Rio de Janeiro 9
Da Nang 8
Miami 8
Nuremberg 8
Charlotte 7
Chennai 7
Johannesburg 7
Bari 6
Bogotá 6
Brasília 6
Frankfurt am Main 6
Haiphong 6
Hải Dương 6
Jakarta 6
Manchester 6
Medellín 6
New Delhi 6
Queens 6
Turin 6
Belo Horizonte 5
Campinas 5
Cincinnati 5
Curitiba 5
Dayton 5
Genoa 5
Kuala Lumpur 5
Lima 5
New Orleans 5
Orem 5
The Dalles 5
Asunción 4
Bologna 4
Cape Town 4
Ferrara 4
Jeddah 4
Krasnodar 4
Lahore 4
Louisville 4
Memphis 4
Montevideo 4
Najaf 4
Pescara 4
Philadelphia 4
Porto Alegre 4
Redmond 4
Secaucus 4
Settimo Torinese 4
Sona 4
Stockholm 4
Totale 5.520
Nome #
Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19 257
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples 257
A case of hepatitis B virus infection in Eritrean Diciotti migrant: phylogenetic analysis and 'mirror effect' 256
Real-time polymerase chain reaction with melting analysis of positive blood culture specimens in bloodstream infections: diagnostic value and turnaround time 250
Migrants rescued on the Mediterranean Sea route: nutritional, psychological status and infectious disease control 240
Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients 234
Alterazioni del sistema interferon in patologie umane: basi biologiche per un intervento terapeutico [The alteration of IFN system in human diseases: Biological basis for a therapy] 232
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 230
SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department 223
Comparison of the Allplex TM Respiratory Panel Assays and the Automated Fast Track Diagnostics Respiratory Pathogens 21 Assay for the Diagnosis of Pediatric Respiratory Viral Infections 221
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 213
). Diagnosi Delle Infezioni Virali 212
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 209
Aspetti virologici della patogenesi dell’infezione da HIV 196
Capitolo 26. Spirochete 183
Cine¬tica di replicazione dell'HIV su C8166: aspetti biologici ed applicativi. 178
Antibodies to IFN in chronic patients treated with rIFN alpha. 177
Influenza B virus infection complicated by life-threatening pericarditis: A unique case-report and literature review 168
Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women 157
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 153
Acquired immunodeficiency virus (HIV-1). Biological aspects and virological diagnosis [Il virus dell'immunodeficienza acquisita (HIV-1). Aspetti biologici e diagnosi virologica] 136
MALDI-TOF MS Identification and Clustering Applied to Enterobacter Species in Nosocomial Setting 135
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision 134
Genomic Epidemiology Unveil the Omicron Transmission Dynamics in Rome, Italy 133
An acute febrile outbreak in a refugee community of an Italian asylum seeker center: lessons learned. Ciccozzi M., Riva E. share co-first authorship 133
Cronobacter sakazakii DNA detection in cerebrospinal fluid of a patient with amyotrophic lateral sclerosis mimic syndrome 133
Classificazione E Struttura Dei Virus Animali 127
Diffuse maculopapular rash: A family cluster during the last Chikungunya virus epidemic in Italy 124
Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C. 123
Genotype I hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics 121
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 120
SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight 120
ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? 119
Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy 112
Azione antivirale dell'interferon e di altri inibitori naturali. Giornale Italiano di Chemioterapia 110
Classificazione E Struttura Dei Virus 110
Anti-interferon (IFN) antibodies in patients with relapsing remitting multipla sclerosis treated with recombinant IFN1a or IFN1b 106
Alteration of thymidine kinase activity in cells treated with an antiviral agent. 105
Cellular factors leading to AZT resistance of HIV. 105
High detection rate of human papillomavirus in anal brushings from women attending a proctology clinic 87
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 87
Multidrug-Resistant Klebsiella pneumoniae Strains in a Hospital: Phylogenetic Analysis to Investigate Local Epidemiology 84
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 81
In Vitro Selection Of Human Immunodeficiency Virus Type 1 Resistant To 3'-Azido-3'-Deoxythymidine. 80
Was Aldo Castellani the inventor of combined and polyvalent vaccines? 78
Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication 77
Quantitative hiv-1 proviral DNA detection: a multicentre analysis 76
IS HUMAN IMMUNODEFICIENCY VIRUS RNA LOAD COMPOSED OF NEUTRALIZED IMMUNE COMPLEXES? 74
“Classificazione e struttura dei virus” 70
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 69
Influence of Hepatitis C virus (HCV) genotype, HCV RNA load and ALT level on reduction of HCV RNA after a single administration of interferon alpha 66
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients 66
Human Immunodeficiency Virus (HIV) DNA load and the level of immunosuppression in Treatment-Naïve HIV-1 Infected Patients 66
STUDIO SULLE MUTAZIONI DI HIV-1 ASSOCIATE A FARMACORESISTENZA NEL PLASMA E NELLE CELLULE MONONUCLEATE DI SANGUE PERIFERICO 65
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients 64
IMMUNOCOMPLESSI CIRCOLANTI (IC) IN PAZIENTI HCV POSITIVI 64
Diagnosi Delle Infezioni Virali 62
Zidovudine induces the expression of cellular resistance affecting its antiviral activity. 62
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 62
IMPROVEMENT OF INTERLEUKIN 2 PRODUCTION, CLONOGENIC CAPABILITY AND RESTORATION OF STROMAL CELL FUNCTION IN HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 PATIENTS AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY 61
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 59
THE NUMBER OF HIV DNA-INFECTED MONONUCLEAR CELLS IS REDUCED UNDER HAART PLUS RECOMBINANT IL-2 59
Spirochete (Cap. 26) 57
Plasma HIV viremia and viral load in lymph nodes 57
Neutralizing and Nonneutralizing antibodies to IFN in hepatitis patients treated with different IFN alpha preparations. 56
New molecular targets in bone metastases 56
The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mrnas for interferon-induced proteins. Intervirology 56
Diagnosi delle Infezioni Virali 56
Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples 55
Decay of HIV Type 1 DNA and development of drug-resistant mutants in patients with primary HIV Type 1 infection receiving highly active antiretroviral therapy. 54
IMPACT OF THE IL28B RS12979860 CT POLYMORPHISM ON THE CYTOMEGALOVIRUS REACTIVATION IN AUTOLOGOUS STEM CELL TRANSPLANT PATIENTS 54
Role of the IL28B Rs12979860 C/T Polymorphism on the Incidence of Clinically-Active Cytomegalovirus Infection in Autologous Stem Cell Transplant Patients 54
Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support 53
Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy 53
Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase. 53
LA COINFEZIONE HIV/HPV 53
Drug-induced cell mediated mechanism leading to resistance of HIV to AZT 53
Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy 52
Susceptibility to measles in migrant population: implication for policy makers. Ceccarelli G., Vita S., Riva E. share co-first authorship 52
Patogenesi Dell'infezione Da HIV: Determinazione Quantitativa Del DNA Provirale Nel Monitoraggio Clinico Terapeutico 52
The SARS-CoV-2 Epidemic: How the Italian Public Is Being Informed 52
Fattori di non progressione nell'infezione da HIV. 52
Human papilloma virus expression in immunocompetent patients with actinic keratosis: A case series 52
“Classificazione e struttura dei virus” 51
Sinergismo fra AZT e ddI nell'infezione da HIV-1: aspetti biologici ed applica¬tivi. 51
The new Chikungunya virus outbreak in Italy possibly originated from a single introduction from Asia. 50
Il virus dell'immunodeficienza acquisita: aspetti biologici e diagnosi virologica. 50
Evaluation of cellular associated HIV-1 DNA levels in HIV-1 infected patients receiving a long term of highly active antiretroviral therapy 50
vitro selection of HIV-1 resistance to ddI is no as efficient as for the other antiretroviral drugs and yields virus which shows reduced cytophatic activity. 50
Genomic and Epidemiologic Surveillance of SARS-CoV-2 in the Pandemic Period: Sequencing Network of the Lazio Region, Italy 49
The prolonged treatment with AZT may induce, in vitro and in vivo, a defect of thymidine kinase activity. 49
Liver cirrhosis after prolonged therapy with IFN-alpha plus IL-2 in a metastatic renal cancer long-term survivor 49
Spirochete 49
MIGLIORAMENTO DELLA PERFORMANCE E GESTIONE DELLA ROUTINE MOLECOLARE NEL LABORATORIO DI VIROLOGIA DEL POLICLINICO UNIVERSITARIO CAMPUS BIO-MEDICO (UCBM) ATTRAVERSO L’UTILIZZO DI UN SISTEMA COMPLETAMENTE AUTOMATICO. 49
Impaired 2′,3′-dideoxy-3′-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11 48
Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay 47
Drug combination Of AZT And Ddi: Synergism Of Action And Prevention of Appearance of AZT-Resistance 47
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy 47
Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein. 47
In Vitro Selection Of Hummunodeficiency Virus Type-1 Resistant To RO-318959 Pro¬teinase Inhibitor. 47
Totale 10.133
Categoria #
all - tutte 74.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 0 0 0 1 1 1 1 12 6 2 177
2022/202381 3 1 1 2 9 1 4 6 3 8 39 4
2023/2024530 13 62 19 44 59 230 2 22 2 23 7 47
2024/20255.522 84 30 185 49 51 97 82 13 377 392 1.920 2.242
2025/20264.292 431 235 250 445 218 209 1.276 296 361 346 121 104
2026/20271.226 54 472 344 356 0 0 0 0 0 0 0 0
Totale 11.852